Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
Aurigene Discovery Technologies Limited
Aurigene Discovery Technologies Limited
Eli Lilly and Company
Curis, Inc.
Wake Forest University Health Sciences
Thomas Jefferson University
BeOne Medicines
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
Ohio State University Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Center for International Blood and Marrow Transplant Research
Wake Forest University Health Sciences
St. Jude Children's Research Hospital
Merck Sharp & Dohme LLC
Genmab
Janssen Research & Development, LLC
Grifols Therapeutics LLC
Janssen Research & Development, LLC
University of Miami
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Arovella Therapeutics Ltd
University of Arizona
Ohio State University Comprehensive Cancer Center
Actuate Therapeutics Inc.
British Columbia Cancer Agency
Eli Lilly and Company
Pfizer
University of Nebraska
Vironexis Biotherapeutics Inc.
City of Hope Medical Center
University of Nebraska
AbbVie
Cellectar Biosciences, Inc.
Novartis
Galapagos NV
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
Caribou Biosciences, Inc.
National Institutes of Health Clinical Center (CC)
BeOne Medicines